SlideShare a Scribd company logo
1 of 1
FIMM - Institute for Molecular Medicine Finland
P.O. Box 20, FI-00014 University of Helsinki, Finland
Biomedicum Helsinki 2U, Tukholmankatu 8, 00290 Helsinki, Finland
www.fimm.fi
A Hi gh- t hr oughput Mas s
Spect r omet r y Bas ed Met hod
f or t he  Quant i t at i ve
Tar get ed  Met abol omi cs
Introduction
Metabolites are the small chemical entities involved in the cellular metabolism.
Metabolomics is a discovery-driven field of science, which aims at the
comprehensive quantitative analysis of all metabolites in any biological system or
a specific physiological state.
Unlike other “omics” studies metabolomics provide the functional readout of a
cellular phenotype.
Fig1: Schematic of the “omic” hierarchy. The flow of information from genes to metabolites
Objective
To develop a high throughput quantitative method in plasma and serum sample
for targeted metabolite profiling across different classes of metabolites in a
single run.
Experimental methods
Standard Solution and Quality Control Sample
Calibration standard solution (multi-analytes and multi-concentrations)
containing 94 polar metabolites at their individual concentration ranges were
prepared at 80/20 Acetonitrile/Water+1% formic acid.
Pooled blood plasma were used as quality controls during the analysis.
Automated Sample Preparation
Polar metabolites were extracted from the human plasma by protein
precipitation method in 96 well plate. Extraction method was automated using
Hamilton Star liquid handling system to increase the throughput and decrease
the inter-assay variations .
Results
We have developed and optimized a method for quantitative analysis of
targeted metabolites in a high throughput manner.
This targeted method allow;
1. Analysis of 96 samples per 24 hours
2. Small sample portion size 100 ul
3. High selectivity provided by MRM
4. High sensitivity for trace level
applications (up to pmol)
5. Quantification of 94 metabolites
covering 15 classes) by using labeled
internal standards or through external
standards
Fig4:Pie chart representing the number of metabolite classes
Method validation
Linearity
Linearity was determined with 11 different concentration levels of the diluted
standards covering 3 orders of magnitude.
Precision (repeatability) and Process Efficiency (PE):
Precision was carried out using five replicates (QC’s). All within-day RSD were
below 10%. PE was calculated by adding known concentrations of spike to the
sample before and after extraction. Figure 5 represents PE ranging from 53-122
% for metabolites for which labeled internal standards were used.
Fig5: Precision and process efficiency of the method
Conclusion
Our developed method has an ability to detect large number of polar
metabolites in wide range of concentrations in a single analysis. This targeted
metabolite profiling method has high potential for the discovery of the
biomarkers for the disease risk, to meet the clinical demands.
UPLC Method
Liquid chromatography was performed on an Acquity UPLC system (Waters
corporation, Milford) coupled with a Hydrophilic Interaction Chromatography
(HILIC) column. HILIC in general is commonly used due to the high compatibility
with mass spectrometry and is powerful technique for the retention of polar
analytes that offers higher selectivity, higher sensitivity and improved
efficiency for quantification of metabolites in biological matrices.
Mass Spectrometry Method:
LC/MS/MS analysis was performed on an Waters XEVO-TQ S triple quadrupole
mass spectrometry by polarity switching electro spray ionization (ESI) using
multiple reaction monitoring (MRM) method.
Fig2: : Experimental protocol for metabolite extraction using robot
Fig3: Waters XEVO-TQS triple quadrupole mass spectrometer and Hamilton star liquid handling system
Vasudev Kantae 1
, Jean-Christophe Yorke 1
,Vidya R. Velagapudi* 1
, Matej Orešič* 2
1 Metabolomics Unit, Technology Centre, Institute for Molecular Medicine Finland FIMM, Helsinki, Finland
2 VTT Technical Research Centre of Finland, Helsinki, Finland * Equal contribution

More Related Content

What's hot

Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug disposition
Supriya hiremath
 
Unveiling the role of network and systems biology in drug discovery
Unveiling the role of network and systems biology in drug discoveryUnveiling the role of network and systems biology in drug discovery
Unveiling the role of network and systems biology in drug discovery
chengcheng zhou
 

What's hot (19)

Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
 
Cadd ppt
Cadd pptCadd ppt
Cadd ppt
 
Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug disposition
 
Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug disposition
 
COMPUTER AIDED DRUG DEVELOPMENT
COMPUTER  AIDED DRUG DEVELOPMENTCOMPUTER  AIDED DRUG DEVELOPMENT
COMPUTER AIDED DRUG DEVELOPMENT
 
Targeted drug delivery systems-TDD (part 1)
Targeted drug delivery systems-TDD (part 1)Targeted drug delivery systems-TDD (part 1)
Targeted drug delivery systems-TDD (part 1)
 
Computational modelling of drug disposition active transport
Computational modelling of  drug disposition active transportComputational modelling of  drug disposition active transport
Computational modelling of drug disposition active transport
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition
 
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
 
Problems with analysis of biological matrices
Problems with analysis of biological matricesProblems with analysis of biological matrices
Problems with analysis of biological matrices
 
Drug Distribution ,Drug Excretion, Active Transport; P–gp, BCRP, Nucleoside T...
Drug Distribution ,Drug Excretion, Active Transport; P–gp, BCRP, Nucleoside T...Drug Distribution ,Drug Excretion, Active Transport; P–gp, BCRP, Nucleoside T...
Drug Distribution ,Drug Excretion, Active Transport; P–gp, BCRP, Nucleoside T...
 
Fed vs Fasted state KKR
Fed vs Fasted state KKRFed vs Fasted state KKR
Fed vs Fasted state KKR
 
Unveiling the role of network and systems biology in drug discovery
Unveiling the role of network and systems biology in drug discoveryUnveiling the role of network and systems biology in drug discovery
Unveiling the role of network and systems biology in drug discovery
 
Gastrointestinal absorption of drugs
Gastrointestinal absorption of drugsGastrointestinal absorption of drugs
Gastrointestinal absorption of drugs
 
Isolation purification technique for Therapeutic Bio molecules : Protein-Peptide
Isolation purification technique for Therapeutic Bio molecules : Protein-PeptideIsolation purification technique for Therapeutic Bio molecules : Protein-Peptide
Isolation purification technique for Therapeutic Bio molecules : Protein-Peptide
 
Metabolic flux analysis
Metabolic flux analysisMetabolic flux analysis
Metabolic flux analysis
 
In vitro metabolite profiling
In vitro metabolite profilingIn vitro metabolite profiling
In vitro metabolite profiling
 
Special concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalenceSpecial concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalence
 
CHROMB17026[1]
CHROMB17026[1]CHROMB17026[1]
CHROMB17026[1]
 

Viewers also liked

Slideshare portada diplomado copy
Slideshare portada diplomado copySlideshare portada diplomado copy
Slideshare portada diplomado copy
AlianzaProactiva
 
Recursos para diseño de base de datos simples
Recursos  para diseño de base de datos simplesRecursos  para diseño de base de datos simples
Recursos para diseño de base de datos simples
CETis 109
 

Viewers also liked (14)

Entertainment and Media Outlook España
Entertainment and Media Outlook España Entertainment and Media Outlook España
Entertainment and Media Outlook España
 
Slideshare portada diplomado copy
Slideshare portada diplomado copySlideshare portada diplomado copy
Slideshare portada diplomado copy
 
Tutorial blogs ΠΣΔ
Tutorial blogs ΠΣΔTutorial blogs ΠΣΔ
Tutorial blogs ΠΣΔ
 
Laureaci 2015 2 (1)
Laureaci 2015 2 (1)Laureaci 2015 2 (1)
Laureaci 2015 2 (1)
 
Prevision jeudi 15 octobre 2015
Prevision jeudi 15 octobre  2015Prevision jeudi 15 octobre  2015
Prevision jeudi 15 octobre 2015
 
Principles of management
Principles of managementPrinciples of management
Principles of management
 
internet sano
internet sanointernet sano
internet sano
 
Scan0001
Scan0001Scan0001
Scan0001
 
slide maes
slide maesslide maes
slide maes
 
Business Snap #4
Business Snap #4Business Snap #4
Business Snap #4
 
CERTIFICATE
CERTIFICATECERTIFICATE
CERTIFICATE
 
Brochure PULSAR Apex Thermal Sights | Optics Trade
Brochure PULSAR Apex Thermal Sights | Optics TradeBrochure PULSAR Apex Thermal Sights | Optics Trade
Brochure PULSAR Apex Thermal Sights | Optics Trade
 
Recursos para diseño de base de datos simples
Recursos  para diseño de base de datos simplesRecursos  para diseño de base de datos simples
Recursos para diseño de base de datos simples
 
crawford inc profile
crawford inc profilecrawford inc profile
crawford inc profile
 

Similar to fimm_Metabolomics-poster2012_VK-2

A Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS Analysis
A Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS AnalysisA Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS Analysis
A Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS Analysis
Bhaswat Chakraborty
 
2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
Alain van Gool
 
Bioanalytical Method Development and Validation for the Estimation of Metopro...
Bioanalytical Method Development and Validation for the Estimation of Metopro...Bioanalytical Method Development and Validation for the Estimation of Metopro...
Bioanalytical Method Development and Validation for the Estimation of Metopro...
BRNSSPublicationHubI
 

Similar to fimm_Metabolomics-poster2012_VK-2 (20)

Metabolic engineering approaches in medicinal plants
Metabolic engineering approaches in medicinal plantsMetabolic engineering approaches in medicinal plants
Metabolic engineering approaches in medicinal plants
 
Bioanalytical Method Validation
Bioanalytical Method ValidationBioanalytical Method Validation
Bioanalytical Method Validation
 
A Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS Analysis
A Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS AnalysisA Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS Analysis
A Systematic Approach to Overcome the Matrix Effect during LC-ESI-MS/MS Analysis
 
Bioanlytical method development
Bioanlytical method developmentBioanlytical method development
Bioanlytical method development
 
USFDA guidelines for bioanalytical method validation
USFDA guidelines for bioanalytical method validationUSFDA guidelines for bioanalytical method validation
USFDA guidelines for bioanalytical method validation
 
2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
 
usfda guidelines for bioanalytical method validation.pptx
usfda guidelines for bioanalytical method validation.pptxusfda guidelines for bioanalytical method validation.pptx
usfda guidelines for bioanalytical method validation.pptx
 
Drug Design:Discovery, Development and Delivery
Drug Design:Discovery, Development and DeliveryDrug Design:Discovery, Development and Delivery
Drug Design:Discovery, Development and Delivery
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 
High Throughput Screening
High Throughput ScreeningHigh Throughput Screening
High Throughput Screening
 
High throughput screening
High throughput screening High throughput screening
High throughput screening
 
GI simulation final.pptx
GI simulation final.pptxGI simulation final.pptx
GI simulation final.pptx
 
Biopra activities
Biopra activitiesBiopra activities
Biopra activities
 
Proteomic and metabolomic
Proteomic and metabolomicProteomic and metabolomic
Proteomic and metabolomic
 
Understanding Bioanalytical Method Validation in a Regulatory Perspective
Understanding Bioanalytical Method Validation in a Regulatory PerspectiveUnderstanding Bioanalytical Method Validation in a Regulatory Perspective
Understanding Bioanalytical Method Validation in a Regulatory Perspective
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
 
GIT Absorption Simulation
GIT Absorption SimulationGIT Absorption Simulation
GIT Absorption Simulation
 
Bioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptBioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.ppt
 
Sample preparation techniques for biological sample
Sample preparation techniques for biological sampleSample preparation techniques for biological sample
Sample preparation techniques for biological sample
 
Bioanalytical Method Development and Validation for the Estimation of Metopro...
Bioanalytical Method Development and Validation for the Estimation of Metopro...Bioanalytical Method Development and Validation for the Estimation of Metopro...
Bioanalytical Method Development and Validation for the Estimation of Metopro...
 

fimm_Metabolomics-poster2012_VK-2

  • 1. FIMM - Institute for Molecular Medicine Finland P.O. Box 20, FI-00014 University of Helsinki, Finland Biomedicum Helsinki 2U, Tukholmankatu 8, 00290 Helsinki, Finland www.fimm.fi A Hi gh- t hr oughput Mas s Spect r omet r y Bas ed Met hod f or t he  Quant i t at i ve Tar get ed  Met abol omi cs Introduction Metabolites are the small chemical entities involved in the cellular metabolism. Metabolomics is a discovery-driven field of science, which aims at the comprehensive quantitative analysis of all metabolites in any biological system or a specific physiological state. Unlike other “omics” studies metabolomics provide the functional readout of a cellular phenotype. Fig1: Schematic of the “omic” hierarchy. The flow of information from genes to metabolites Objective To develop a high throughput quantitative method in plasma and serum sample for targeted metabolite profiling across different classes of metabolites in a single run. Experimental methods Standard Solution and Quality Control Sample Calibration standard solution (multi-analytes and multi-concentrations) containing 94 polar metabolites at their individual concentration ranges were prepared at 80/20 Acetonitrile/Water+1% formic acid. Pooled blood plasma were used as quality controls during the analysis. Automated Sample Preparation Polar metabolites were extracted from the human plasma by protein precipitation method in 96 well plate. Extraction method was automated using Hamilton Star liquid handling system to increase the throughput and decrease the inter-assay variations . Results We have developed and optimized a method for quantitative analysis of targeted metabolites in a high throughput manner. This targeted method allow; 1. Analysis of 96 samples per 24 hours 2. Small sample portion size 100 ul 3. High selectivity provided by MRM 4. High sensitivity for trace level applications (up to pmol) 5. Quantification of 94 metabolites covering 15 classes) by using labeled internal standards or through external standards Fig4:Pie chart representing the number of metabolite classes Method validation Linearity Linearity was determined with 11 different concentration levels of the diluted standards covering 3 orders of magnitude. Precision (repeatability) and Process Efficiency (PE): Precision was carried out using five replicates (QC’s). All within-day RSD were below 10%. PE was calculated by adding known concentrations of spike to the sample before and after extraction. Figure 5 represents PE ranging from 53-122 % for metabolites for which labeled internal standards were used. Fig5: Precision and process efficiency of the method Conclusion Our developed method has an ability to detect large number of polar metabolites in wide range of concentrations in a single analysis. This targeted metabolite profiling method has high potential for the discovery of the biomarkers for the disease risk, to meet the clinical demands. UPLC Method Liquid chromatography was performed on an Acquity UPLC system (Waters corporation, Milford) coupled with a Hydrophilic Interaction Chromatography (HILIC) column. HILIC in general is commonly used due to the high compatibility with mass spectrometry and is powerful technique for the retention of polar analytes that offers higher selectivity, higher sensitivity and improved efficiency for quantification of metabolites in biological matrices. Mass Spectrometry Method: LC/MS/MS analysis was performed on an Waters XEVO-TQ S triple quadrupole mass spectrometry by polarity switching electro spray ionization (ESI) using multiple reaction monitoring (MRM) method. Fig2: : Experimental protocol for metabolite extraction using robot Fig3: Waters XEVO-TQS triple quadrupole mass spectrometer and Hamilton star liquid handling system Vasudev Kantae 1 , Jean-Christophe Yorke 1 ,Vidya R. Velagapudi* 1 , Matej Orešič* 2 1 Metabolomics Unit, Technology Centre, Institute for Molecular Medicine Finland FIMM, Helsinki, Finland 2 VTT Technical Research Centre of Finland, Helsinki, Finland * Equal contribution